Oberweis Asset Management Inc/
Source: SEC Form 13F · as of Mar 2026Oberweis Asset Management Inc/ holds 19 biotech & pharma companies tracked by BioSniper, totaling $290.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$290.9M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Globus Medical Inc. (GMED)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GMEDGlobus Medical Inc. | 392,200 | $33.8M |
| ARQTArcutis Biotherapeutics, Inc. | 1,365,941 | $32.2M |
| MMSIMerit Medical Systems Inc. | 424,209 | $29.2M |
| ICUIICU Medical Inc. | 203,710 | $26.3M |
| INDVIndivior Pharmaceuticals, Inc. | 653,413 | $19.9M |
| CPRXCATALYST PHARMACEUTICALS, INC. | 780,570 | $19.3M |
| ALHCAlignment Healthcare Inc. | 966,600 | $17.0M |
| ANIPANI PHARMACEUTICALS INC | 221,386 | $17.0M |
| KNSAKiniksa Pharmaceuticals International, plc | 318,634 | $15.3M |
| PAHCPHIBRO ANIMAL HEALTH CORP | 277,100 | $15.3M |
| HALOHALOZYME THERAPEUTICS, INC. | 219,930 | $14.2M |
| LQDALiquidia Corp | 372,100 | $14.0M |
| ADPTAdaptive Biotechnologies Corp | 806,951 | $11.2M |
| ETONEton Pharmaceuticals, Inc. | 439,300 | $10.8M |
| CRMDCorMedix Inc. | 1,211,115 | $8.2M |
| BVSBioventus Inc. | 628,114 | $5.7M |
| JNJJOHNSON & JOHNSON | 2,294 | $561K |
| AMGNAMGEN INC | 1,036 | $364K |
| MRKMerck & Co., Inc. | 1,730 | $208K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.